Best BPC-157 Providers in 2026 — Ranked & Reviewed
BPC-157 is a synthetic 15-amino-acid peptide derived from a sequence in human gastric juice, widely discussed for gut, tendon, and soft-tissue healing. Its evidence is almost entirely from rats; no controlled human trial exists, and the only human data are three small uncontrolled studies with 30 people in total. In a draft enforcement policy from October 28, 2026, HHS says it does not intend to bring enforcement action against licensed 503A pharmacies and physicians who compound it for a specific patient and meet ten conditions, which opens a route to a prescribed product. That is enforcement discretion, not FDA approval, and most BPC-157 sold online is still an unregulated research chemical. See below for the current status.
Lowest verified price: $109/mo (Enhanced, ongoing rate)16 providers compared
New to BPC-157? Read our full BPC-157 guide — evidence, dosing, safety and side effects.
BPC-157 dosage: what the FDA and published studies actually say.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
16 bpc-157 providers compared · independently scored against our six-factor methodology.
Status as of October 30, 2026
Under a draft HHS policy announced October 28, 2026, HHS says it will not take enforcement action against 503A pharmacies and physicians compounding BPC-157 under ten conditions. It is not FDA approval, and the policy is not final or binding; public comments are open until November 13, 2026.
- Forms the policy covers
- Injection (under the skin or into muscle), oral, or topical. A nasal spray is not covered and is labeled that way.
- Left off this list
- Blends such as BPC-157 with TB-500.
- Key conditions
- A patient-specific prescription, a single-ingredient product, a certificate of analysis from an FDA-registered manufacturer, and MedWatch reporting, plus documented human oral bioavailability for oral forms (ten conditions in all).
- What a listing means
- The clinic sells single-ingredient BPC-157 on its own site (checked October 30, 2026). We have not confirmed its pharmacy meets the policy's other conditions. Ask whether a 503A pharmacy (not a 503B outsourcing facility) fills your order, and in what device.
- BPC-157 was in FDA's Category 2 from September 2023 until April 22, 2026. It is not FDA-approved.
More detail: how the HHS policy works, how to get BPC-157 online, and oral BPC-157 vs injection.
Compare the top providers at a glance
Logos, our editorial rating, price, the form each clinic sells, and coverage. Forms outside the HHS policy are marked “not covered.”
- ★ Editor's PickFrom /mo$209Coverage50 statesForm soldInjection
- Nationwide CoverageFrom /mo$145Coverage50 statesForm soldInjection
- From /moCheck pricingCoverage50 statesForm soldInjection
- From /moCheck pricingCoverage50 statesForm soldSold as supplement capsules · not covered
- From /mo$125Coverage47 statesForm soldInjection
- From /moCheck pricingCoverageCheck intakeForm soldInjectionNasal spray · not covered
- Best BudgetFrom /mo$109CoverageCheck intakeForm soldInjection
- From /moCheck pricingCoverage28 statesForm soldInjectionOral
- From /mo$169Coverage36 statesForm soldInjection
- From /moCheck pricingCoverage50 statesForm soldInjection
- From /mo$169CoverageCheck intakeForm soldInjection
compounded peptides priced up front, including KPV, MOTS-c, epitalon and semax nasal spray
From /mo$116CoverageCheck intakeForm soldInjectionOral- From /moCheck pricingCoverageCheck intakeForm soldInjection
- From /mo$320CoverageCheck intakeForm soldInjection
- From /moCheck pricingCoverage50 statesForm soldInjection
- From /moCheck pricingCoverageCheck intakeForm soldInjection
| Provider | Rating | From /mo | Form sold | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick | $209 | Injection | 50 states | Visit → | |
Nationwide Coverage | $145 | Injection | 50 states | Visit → | |
 | Check pricing | Injection | 50 states | Visit → | |
 | Check pricing | Sold as supplement capsules · not covered | 50 states | Visit → | |
 | $125 | Injection | 47 states | Visit → | |
 | Check pricing | InjectionNasal spray · not covered | Check intake | Visit → | |
Best Budget | $109 | Injection | Check intake | Visit → | |
 | Check pricing | InjectionOral | 28 states | Visit → | |
 | $169 | Injection | 36 states | Visit → | |
 | Check pricing | Injection | 50 states | Visit → | |
 | $169 | Injection | Check intake | Visit → | |
 compounded peptides priced up front, including KPV, MOTS-c, epitalon and semax nasal spray | $116 | InjectionOral | Check intake | Visit → | |
 | Check pricing | Injection | Check intake | Visit → | |
 | $320 | Injection | Check intake | Visit → | |
 | Check pricing | Injection | 50 states | Visit → | |
 | Check pricing | Injection | Check intake | Visit → |
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
Detailed Reviews
A note on prices below: any dollar figure in these provider summaries refers to that clinic’s GLP‑1 weight-loss program, not to BPC-157. The BPC-157 price is the one beside each clinic in the comparison table above, read from that clinic’s own product page. Where it reads “Check pricing”, the clinic prescribes BPC-157 but publishes no price for it — you are quoted after the consultation.
Pepti
Pepti is a Delaware-registered telehealth platform selling doctor-prescribed compounded peptides and GLP-1s, with a published shipping list of 49 states plus DC. Injectable semaglutide starts at $99 and tirzepatide at $159 per 28-day supply, rising with dose to $199 and $319. Each price covers medication, physician review, labs, refill management and shipping, with no membership fee. Pepti is a platform, not a prescriber, and does not bill insurance.
Score Breakdown
Pros
- ✓Injectable semaglutide starts at $99 and tirzepatide at $159 all-in, with no membership fee on top.
- ✓Publishes the exact price for every dose of both drugs, so you can see what titrating up will cost before you start.
- ✓Publishes a shipping list of 49 states plus DC, and a provider denial means a full refund.
- ✓Names the reviewing physician, Dr. Gene Lee MD, and posts third-party sterility and potency results by lot.
Cons
- ✗Billed every 28 days rather than monthly, so you pay 13 times a year, not 12.
- ✗Price rises with dose: semaglutide tops out at $199 and tirzepatide at $319 per supply.
- ✗The site says it serves 50 states, but its own list leaves out Oklahoma and counts DC instead.
- ✗No compounding pharmacy is named in advance; you only learn it from your medication label.
- ✗The listed address, a Newark Delaware suite, is a shared registered-agent address rather than a clinical office.
- ✗Cash-pay only with no insurance billing, and medication can't be refunded once it ships.
Live Vital
Verified partnerLive Vital is a physician-led telehealth practice founded by Dr. Patrick Taylor, MD, offering compounded GLP-1 weight loss (semaglutide advertised from $99/mo and tirzepatide from $183/mo, both sold as 10-week protocols) alongside peptide and hormone therapy. Every plan is doctor-prescribed, filled by a licensed US pharmacy, and shipped to your door, with unlimited care-team messaging. Fully telehealth in all 50 states.
Score Breakdown
Pros
- ✓Physician-led: founded by Dr. Patrick Taylor, MD; all treatments doctor-prescribed via the clinical team
- ✓Transparent published pricing: semaglutide from $99/mo, tirzepatide from $183/mo, both on 10-week protocols
- ✓Every plan includes doctor prescribing, licensed-pharmacy medication, and direct-to-door shipping
- ✓Unlimited messaging with the care team; you can cancel at any time, effective at the end of the current billing period
- ✓Fully telehealth in all 50 states
Cons
- ✗The advertised '/mo' rate divides a 10-week protocol by three, so a calendar month costs about $130 or $239
- ✗Doesn't accept insurance (HSA/FSA funds only)
- ✗Compounding pharmacy isn't named (only 'a licensed US pharmacy')
- ✗Medications and lab work are generally non-refundable once ordered, and consultation refunds are at the practice's discretion
- ✗Also a peptide/longevity practice; those peptides are not FDA-approved (the site discloses this)
Ivologist
Ivologist sells compounded semaglutide from $149/month and tirzepatide from $249/month, with a three-month prepay option at $397 and $697. LegitScript certified. Available in all 50 states. Also offers hormone therapy, hair regrowth, IV therapy, and longevity treatments. Over 20,000 patients served.
Score Breakdown
Pros
- ✓LegitScript certified
- ✓All 50 states coverage
- ✓Three-month prepay option avoids recurring billing entirely
- ✓Over 20,000 patients served
- ✓Both semaglutide and tirzepatide available
- ✓Consultation, medication, injection supplies and shipping quoted in one price
Cons
- ✗No legal entity name or physical address disclosed on site
- ✗Broader platform, not a GLP-1 specialist
- ✗$75 deposit required to book the provider consultation, and the site does not say whether it is credited toward the program
Ivy Rx
Ivy Rx is a telehealth brand that sells compounded semaglutide and tirzepatide injections, a lower-dose microdose line, and peptide therapies such as NAD+ and sermorelin. It advertises the same price at every dose, free shipping, same-day clinician review and no lab work, but exact plan prices appear only at checkout after the health questionnaire.
Score Breakdown
Pros
- ✓Same price at every dose, so your cost doesn't climb as the dose goes up
- ✓No lab work required and same-day clinician review
- ✓Free, discreet shipping on all medications
- ✓Offers both compounded semaglutide and tirzepatide, plus a microdose option
- ✓Cancel anytime with no long-term commitment or cancellation fee, per its help center
- ✓Large, active Trustpilot profile with a 4.7 rating from over 7,500 reviews
Cons
- ✗Advertises GLP-1 'from $77' a month, but real plan prices only appear at checkout after the questionnaire and account creation
- ✗Refund rules conflict: one page says returns are not accepted, while the terms allow a refund request within 15 days
- ✗Subscriptions auto-renew, and the terms let Ivy Rx raise prices at any time
- ✗Compounded medications are not FDA-approved
- ✗Brand-name Ozempic and Mounjaro are listed at $1,399 with no billing period stated
OurView Health
OurView Health is an online telehealth platform for weight loss, hormone therapy and wellness, with care from licensed providers through the Telegra network. Compounded semaglutide is $109/mo and tirzepatide $129/mo at any prescribed dose, or $99 and $119/mo on a 3-month prepay, with no membership or shipping fee. Medication is compounded by Boudreaux's New Drug Store, a 503A pharmacy in Louisiana. Service covers 46 states plus DC.
Score Breakdown
Pros
- ✓Low flat pricing: compounded semaglutide $109/mo and tirzepatide $129/mo at any prescribed dose
- ✓No membership fee and free shipping; a 3-month prepay drops the price to $99 or $119/mo
- ✓Names its pharmacy (Boudreaux's New Drug Store, a Louisiana 503A) and provider network (Telegra)
- ✓LegitScript seal on the site and a published list of states served
- ✓No contracts; your card is only charged after a provider approves treatment
Cons
- ✗Not available in Arkansas, Connecticut, Hawaii or New Jersey
- ✗Only 1-month or 3-month plans; the 3-month price is paid upfront
- ✗All sales are final once medication ships
- ✗The website is run by a marketing agency (Kickstart Social), and the operating company isn't named
- ✗Terms set Georgia law but require arbitration in San Diego, California
How we rank & what counts as “legit”
Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.
Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].
Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].
Frequently Asked Questions
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.